$1.11
-0.04[-3.48%]
At close: Apr 26
$1.11
0[0.00%]
After Hours: 7:22PM EDT
Bolt Biotherapeutics
(NASDAQ:BOLT)Bolt Biotherapeutics Stock (NASDAQ:BOLT), Analyst Ratings, Price Targets, Predictions
Bolt Biotherapeutics Inc has a consensus price target of $5, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 22, 2024, August 8, 2023, and August 3, 2023. With an average price target of $8 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 620.72% upside for Bolt Biotherapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
SVB Leerink
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Bolt Biotherapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | $8 → $8 | Maintains | Buy | Get Alert |
| 08/08/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 06/05/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 05/12/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 260.36% | SVB Leerink | Daina Graybosch | → $4 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/12/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/30/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 170.27% | Morgan Stanley | Matthew Harrison | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 10/04/2022 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 620.72% | HC Wainwright & Co. | Edward White | → $8 | Initiates | → Buy | Get Alert |
| 08/11/2022 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 260.36% | SVB Leerink | Daina Graybosch | $8 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/17/2022 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 350.45% | Morgan Stanley | Matthew Harrison | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 01/06/2022 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 890.99% | Morgan Stanley | Matthew Harrison | $45 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/10/2021 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 2872.97% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
| 08/16/2021 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 3053.15% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
| 05/17/2021 | BOLT | Buy Now | Bolt Biotherapeutics | $1.11 | 2872.97% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Bolt Biotherapeutics (BOLT)?
The latest price target for Bolt Biotherapeutics (NASDAQ: BOLT) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $8.00 expecting BOLT to rise to within 12 months (a possible 620.72% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bolt Biotherapeutics (BOLT)?
The latest analyst rating for Bolt Biotherapeutics (NASDAQ: BOLT) was provided by HC Wainwright & Co., and Bolt Biotherapeutics maintained their buy rating.
When was the last upgrade for Bolt Biotherapeutics (BOLT)?
The last upgrade for Bolt Biotherapeutics Inc happened on May 12, 2023 when SVB Leerink raised their price target to $4. SVB Leerink previously had a market perform for Bolt Biotherapeutics Inc.
When was the last downgrade for Bolt Biotherapeutics (BOLT)?
The last downgrade for Bolt Biotherapeutics Inc happened on August 11, 2022 when SVB Leerink changed their price target from $8 to $4 for Bolt Biotherapeutics Inc.
When is the next analyst rating going to be posted or updated for Bolt Biotherapeutics (BOLT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bolt Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bolt Biotherapeutics was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Bolt Biotherapeutics (BOLT) correct?
While ratings are subjective and will change, the latest Bolt Biotherapeutics (BOLT) rating was a maintained with a price target of $8.00 to $8.00. The current price Bolt Biotherapeutics (BOLT) is trading at is $1.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.